Hyperimmune globulin is a product derived from plasma from various donors. Hyperimmune globulins have activity against hepatitis B, rabies, tetanus toxins, varicella-zoster, and others. Hyperimmune globulins when administered provide passive immunity to the patients. This is an active immunity against viruses and others.
MARKET SCOPE
The "Global Hyperimmune Globulin Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of the Hyperimmune Globulin market with detailed market segmentation by drug class and distribution channel. The report provides key statistics on the market status of the leading Hyperimmune Globulin market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
- Based on product type the market is segmented as, immunoglobulins for hepatitis B, immunoglobulins for rabies, immunoglobulins for tetanus, RHO (D) immunoglobulins, and others.
- Based on the application the market is segmented as, immunodeficiency, autoimmune disease, and acute infection.
- Based on dosage form the market is segmented as, powdered form and liquid form.
- Based on end user the market is segmented as, hospitals, government institutions, the private sector, and, others.
MARKET DYNAMICS
Drivers:
- Rising prevalence of hepatitis B, rabies, tetanus toxins, varicella-zoster, and others.
- Rising adult and geriatric population with active acute infections.
- Increasing use of passive immunity.
- Extensive R&D efforts by biotechnology and pharmaceutical companies to develop novel immunoglobulin therapies are expected to fuel market growth.
Restraints:
- Whereas, the high cost of manufacturing and treatment is expected to restrain the market growth during the forecast period.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 concerning five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South and Central America. The Hyperimmune Globulin market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.
The report analyzes factors affecting the market from both the demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trends. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South and Central America after evaluating political, economic, social, and technological factors affecting the Hyperimmune Globulin market in these regions.
IMPACT OF COVID-19 ON HYPERIMMUNE GLOBULIN MARKET
COVID-19 first began in Wuhan (China) in December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms of confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. The shutdown of various plants and factories has affected the global supply chains and negatively impacted the manufacturing, delivery schedules, and sales of products in the global market. Few companies have already announced possible delays in product deliveries and slumps in future sales of their products. According to the current market situation, the report further assesses the present and future effects of the COVID-19 pandemic on the overall market, giving more reliable and authentic projections In addition to this, the global travel bans imposed by countries in Europe, Asia-Pacific, and North America are affecting the business collaborations and partnerships opportunities.
MARKET PLAYERS
The report covers key developments in the Hyperimmune Globulin market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals, and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnerships & collaborations. These activities have paved the way for the expansion of the business and customer base of market players. The market payers from the Hyperimmune Globulin market are anticipated to lucrative growth opportunities in the future with the rising demand for Hyperimmune Globulin in the global market.
The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the Hyperimmune Globulin market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.
- GRIFOLS
- BIOTEST
- HUALAN BIO
- CNBG
- CSL BEHRING
- EMERGENT
- ADMA BIOLOGICS